Sign in
CompletedPhase 4

Randomized clinical trial comparing the diagnostic quality and diagnostic accuracy of pulmonary CT angiography performed with spectral CT among three iodinated contrast administration protocols, with 20, 30 and 40 mL

Key facts

Who runs it
Hospital General Universitario Dr. Balmis
Where
Spain1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 4
People taking part
150 people enrolled
Started
11 Nov 2024
Ended
1 Aug 2025
Type of study
Interventional
Record updated
16 October 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients referred to our department for a pulmonary CT angiography to rule out pulmonary thromboembolism

Who cannot take part

  • Allergic to iodinated contrast
  • Renal failure with estimated glomerular filtration rate <30 mL/min
  • Patient refusal to participate in the study
  • Weight less than 50 or more than 100 kg respectively

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

By measuring attenuation at pulmonary arteries, quality of perfusion maps and the diagnostic accuracy for pulmonary thromboembolism we aim to qualitatively and quantitatively compare three protocols for the administration of iodinated contrast in pulmonary CT angiography, one with 20 mL of contrast medium diluted with 20 mL of saline, another with 30 mL and another with 40 mL of iodinated contrast.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
16 October 2024